The Rise of "Clinical Metagenomics": Are We Entering the Age of Pathogen-Agnostic Testing?
A major trend in the 2026 Microbiology Testing Market is the shift from "Targeted Panels" to "Clinical Metagenomics." For years, doctors had to guess which test to order; in 2026, "Pathogen-Agnostic" Next-Generation Sequencing (NGS) allows labs to sequence every piece of DNA in a patient's sample simultaneously. This "Shotgun" approach can identify any bacteria, virus, or fungus in a single...
0 Comments 0 Shares 3 Views 0 Reviews